Börjeson-Forssman-Lehmann Syndrome (BFLS)

Börjeson-Forssman-Lehmann syndrome—short name BFLS—is a rare genetic condition that mainly affects learning, growth, hormones, and body shape. It happens when there is a disease-causing change (a pathogenic variant) in a single gene called PHF6, which sits on the X chromosome. Because it is on the X chromosome, BFLS is seen mostly in males; females can be mildly or variably affected, especially if X-inactivation is skewed. Common signs include intellectual disability, developmental delay, low muscle tone in infancy, obesity (especially around the trunk/abdomen), hypogonadism (under-function of the testes/ovaries), sometimes seizures, and distinctive facial features (for example fleshy/large ears, thick lips, and certain eye and brow shapes). The condition is lifelong, but many health issues can be identified early and managed with supportive care, therapies, and targeted treatments for symptoms (for example, seizures or cryptorchidism). A precise diagnosis is made by genetic testing that confirms a pathogenic PHF6 variant. rarediseases.info.nih.gov+2orpha.net+2

Börjeson-Forssman-Lehmann syndrome (BFLS) is a rare, inherited condition caused by changes in a gene called PHF6 on the X-chromosome. Many people with BFLS have learning disability, slower development in childhood, low muscle tone, short height, weight gain, hormone problems (like small testes or delayed puberty), seizures, and a typical face shape. The exact features differ a lot from person to person and even within the same family. There is no single “BFLS medicine”; care focuses on treating each symptom early and well. Orpha+1

BFLS follows an X-linked pattern. It is seen more often in males, but females can be affected, especially with skewed X-inactivation. Diagnosis is confirmed with a genetic test that finds a disease-causing change in PHF6. Early recognition matters because it guides therapy plans, helps with school supports, and informs family planning. PubMed+1

The PHF6 protein helps control how other genes switch on and off during development, especially in the brain, pituitary, and face. When PHF6 does not work, brain circuits, growth, and hormone control can be affected, which explains the mix of learning, behavior, seizure, growth, and endocrine features. Understanding this biology supports a multi-disciplinary care plan rather than a single “cure.” ScienceDirect

---

Other names

• BFLS

• Börjeson–Forssman–Lehmann syndrome (with or without the umlaut/accents)

• OMIM #301900 (catalog number used in medical genetics)

• Intellectual disability–epilepsy–endocrine disorders syndrome (descriptive synonym used in some references) Wikipedia+1

---

Types

BFLS is caused by variants in one gene, PHF6. There is no rigid, universally accepted clinical “subtype” system. Instead, doctors describe presentations based on who is affected and which features dominate. These “types” are helpful ways to think about BFLS in a clinic:

1. Classic male presentation. Moderate–severe intellectual disability, truncal obesity, hypogonadism/undescended testes, possible seizures, distinctive facial features. PubMed+1

2. Female presentation with PHF6 variant. Variable learning and behavioral issues; some may have obesity, peripheral neuropathy, or mild intellectual disability; severity can be influenced by X-inactivation. nature.com

3. Endocrine-predominant presentation. Hypogonadism, delayed puberty, gynecomastia (males), short stature; learning challenges present but hormones drive referral. e-bnr.org

4. Neuro-predominant presentation. Developmental delay, hypotonia in infancy, seizures, and movement/coordination issues; facial and endocrine features may be subtle early on. rarediseases.info.nih.gov

5. Behavioral/psychiatric-prominent presentation. Anxiety, mood symptoms, or challenging behaviors with underlying PHF6 variant and supportive physical signs. ScienceDirect

6. Atypical/partial phenotype. Individuals with confirmed PHF6 variants who do not meet the full “classic” picture (more often reported in females). nature.com

---

Causes

Key message: The cause of BFLS is a pathogenic variant in the PHF6 gene. Below are 20 concrete, gene-level causes and biological modifiers that explain why the condition appears and why it varies between people:

1. Loss-of-function variants in PHF6 (for example, nonsense or frameshift changes) that truncate the protein. These are common in BFLS. PubMed+1

2. Missense variants that change one amino acid and alter PHF6 function. Severity can vary by location of the change. nature.com

3. Splice-site variants that disrupt normal RNA splicing and reduce functional PHF6 protein. PubMed

4. Small deletions/insertions within PHF6 that shift the reading frame. ClinGen

5. Larger intragenic deletions/duplications of PHF6 exons detected by copy-number testing (for example, MLPA/CMA). ClinGen

6. De novo variants (new in the child) with no family history—seen in both males and females. nature.com

7. Inherited X-linked variants passed from a carrier mother to a son; classic pattern for BFLS. National Organization for Rare Disorders

8. Skewed X-inactivation in females leading to expression of the altered X chromosome in more cells, increasing symptom severity. jcrpe.org

9. Mosaicism (variant present in only some cells) in the child or a parent, which can make features milder or cause recurrence in a family. (Reported across X-linked disorders and relevant to PHF6.) nature.com

10. Variants that disrupt PHF6’s PHD-finger domains (protein regions important for chromatin interactions), altering gene regulation during development. ClinGen

11. Variants affecting promoter/5′ regions that reduce PHF6 expression (less common but biologically plausible and reported in gene-level curation). ClinGen

12. Pathogenic variants clustered in functionally critical exons (hotspots) that correlate with classic features. nature.com

13. Secondary hormonal consequences (for example, hypothalamic–pituitary–gonadal axis under-activity) downstream of PHF6 disruption—these modify the clinical picture (hypogonadism). e-bnr.org

14. Neurodevelopmental pathway effects—PHF6 is expressed in developing brain and pituitary; disruption modifies learning/behavior. Wikipedia

15. Metabolic effects (hypometabolism/obesity phenotype) linked to PHF6 variant consequences, contributing to body composition changes. PubMed

16. Genetic background (other common variants) that can soften or worsen learning/behavioral outcomes. (General principle in rare diseases; observed variability in PHF6 cohorts.) nature.com

17. Sex-specific effects because PHF6 is on the X chromosome (males usually more affected; females variable). rarediseases.info.nih.gov

18. Epigenetic changes interacting with PHF6’s chromatin-related roles, potentially modifying expression profiles during development. ClinGen

19. Specific nonsense variants documented in ClinVar (for example p.Arg274Ter) proving loss-of-function as a mechanism in patients. NCBI

20. Historical linkage to Xq26–q27 region before PHF6 discovery—evidence that BFLS maps to and is caused by genes in this locus, now known to be PHF6. PubMed

---

Symptoms and signs

Symptoms vary from person to person. Not everyone has all of them. Males are usually more affected than females because of X-linkage. rarediseases.info.nih.gov

1. Developmental delay in infancy. Babies may roll, sit, stand, and walk later than peers. Hypotonia (low muscle tone) is common early on. rarediseases.info.nih.gov

2. Intellectual disability. Ranges from mild to severe. Learning, language, and problem-solving are affected through life. PubMed

3. Hypotonia (floppy muscles) in infants. Makes feeding and motor skills harder at first. e-bnr.org

4. Obesity, especially trunk/abdomen. Weight tends to increase with age; body fat often collects around the middle. monarchinitiative.org

5. Hypogonadism and delayed puberty (males). Small testes, undescended testes, low sex hormones, and sometimes gynecomastia. PubMed

6. Distinctive facial features. Large or fleshy ears, thicker lips, eyelid shape differences, and a heavy or prominent brow ridge in some. orpha.net

7. Seizures. Some individuals have epilepsy that needs standard treatment and monitoring. rarediseases.info.nih.gov

8. Short stature. Height can be below average; growth problems may be noted in childhood. e-bnr.org

9. Finger and toe differences. Tapered fingers, short toes, or other minor limb features may be seen. e-bnr.org

10. Behavioral and emotional concerns. Anxiety, mood symptoms, or challenging behaviors can occur and benefit from behavioral therapy. ScienceDirect

11. Vision issues. Some people develop refractive errors, nystagmus, or cataracts and need eye care. Wikipedia

12. Hearing issues. Hearing loss can occur and should be screened and treated early. Wikipedia

13. Peripheral neuropathy in some. Numbness, reduced reflexes, or foot problems can be part of the adult/female phenotype. Wikipedia

14. Metabolic/energy features. Some reports note hypometabolism and fatigue-like complaints. Lifestyle and endocrine care help. PubMed

15. Scoliosis or kyphosis (curved spine). Posture problems may need orthopedic review and physical therapy. Wikipedia

---

Diagnostic tests

A) Physical examination (bedside assessment)

1. General pediatric/genetic exam. The clinician looks for the whole pattern: growth charts, fat distribution (truncal), facial features, and limb findings. This pattern suggests BFLS and guides genetic testing. orpha.net

2. Developmental assessment. Age-appropriate tools check gross motor, fine motor, speech/language, and social skills to map needs for therapy. rarediseases.info.nih.gov

3. Endocrine/puberty staging (Tanner staging). Pubertal progress, testicular size, and gynecomastia are recorded; this supports the hypogonadism profile and directs hormone tests. e-bnr.org

4. Neurologic exam. Tone, reflexes, coordination, and seizure history are reviewed to plan EEG or imaging. rarediseases.info.nih.gov

5. Ophthalmology and otology screens. Vision and hearing checks are part of routine care because problems are relatively common in BFLS. Wikipedia

B) Manual/functional tests (simple clinic maneuvers or standardized scales)

6. Growth and body-composition tracking (BMI, waist circumference). Repeated measures show the obesity pattern and help tailor nutrition/activity plans. monarchinitiative.org

7. Standardized cognitive testing. Tools like IQ or adaptive behavior scales identify strengths and needs for education plans and supports. rarediseases.info.nih.gov

8. Behavior rating scales. Parent/teacher questionnaires document anxiety, attention, or behavior symptoms to guide therapy. ScienceDirect

9. Gross/fine motor function tests. Simple timed tasks and occupational/physical therapy assessments guide therapy goals in hypotonia and coordination issues. rarediseases.info.nih.gov

C) Laboratory and pathological tests

10. Targeted single-gene sequencing of PHF6. Sanger or NGS reads the PHF6 gene to find a pathogenic variant—this is the definitive test for BFLS. PubMed

11. NGS intellectual-disability panel or whole-exome/genome sequencing. Used when BFLS is suspected among many possibilities; it still detects PHF6 variants. nature.com

12. Copy-number analysis (MLPA or chromosomal microarray). Checks for missing or duplicated exons in PHF6 that sequencing alone might miss. ClinGen

13. ClinVar/clinical lab confirmation and segregation testing. Confirms the variant and checks parents/siblings to understand inheritance and recurrence risk. NCBI

14. Hormone panel for hypogonadism. LH/FSH, testosterone/estradiol, and sometimes prolactin/thyroid tests clarify endocrine status and guide treatment. e-bnr.org

15. Metabolic profile (lipids, glucose/HbA1c, liver function). Screens weight-related risks that can accompany truncal obesity and guides lifestyle plans. monarchinitiative.org

D) Electrodiagnostic tests

16. Electroencephalogram (EEG). Records brain activity if seizures are suspected or diagnosed; helps choose antiseizure medications. rarediseases.info.nih.gov

17. Brainstem auditory evoked responses (BAER). Objective hearing pathway test when standard hearing tests are hard to complete. Wikipedia

18. Nerve conduction studies/electromyography (NCS/EMG). Considered if neuropathy signs appear (for example, numbness, reduced reflexes). Wikipedia

E) Imaging tests

19. Brain MRI. Looks for structural differences or injury patterns, and rules out other causes of seizures/developmental delay. Wikipedia

20. Pelvic/abdominal ultrasound (males) and testicular imaging. Helps locate undescended testes and plan surgery; also documents gonadal size. e-bnr.org

Non-pharmacological treatments (therapies and other supports)

1. Early Intervention (birth–5 years)
   Description: A coordinated program that includes developmental therapy, parent coaching, and goal-based play to build communication, movement, and self-help skills. Purpose: Speed skill gain and reduce developmental gaps before school. Mechanism: Repetitive, enriched practice strengthens brain connections (neuroplasticity) while routines and parent strategies create many chances to learn every day. rarediseases.info.nih.gov

2. Speech-Language Therapy
   Description: Regular sessions targeting first sounds, words, understanding, and social communication; augmentative and alternative communication (AAC) if speech is limited. Purpose: Improve communication and reduce frustration and behavior outbursts linked to not being understood. Mechanism: Structured language input and AAC give the brain clear models and reliable ways to express needs, which lowers stress and supports learning. rarediseases.info.nih.gov

3. Occupational Therapy (OT)
   Description: Focus on fine-motor skills (grasping, writing, feeding), sensory processing, and daily living skills like dressing and hygiene. Purpose: Increase independence at home and school and reduce sensory overload. Mechanism: Task-specific practice and graded sensory input help organize motor and sensory pathways and improve attention and self-regulation. rarediseases.info.nih.gov

4. Physical Therapy (PT)
   Description: Exercises and play that build strength, posture, balance, and walking. Orthotics may help foot posture; home programs keep gains between visits. Purpose: Reduce falls, improve participation, and prevent contractures or scoliosis. Mechanism: Repeated, progressive movement practice rewires motor circuits and strengthens core and limb muscles, improving endurance and coordination. rarediseases.info.nih.gov

5. Individualized Education Program (IEP) and Special Education
   Description: School plan with measurable goals, classroom supports, and related services (SLP, OT, PT, behavioral supports). Purpose: Ensure access to learning in the least restrictive setting. Mechanism: Environmental adaptations and tailored instruction compensate for processing speed, attention, and language differences common in BFLS. rarediseases.info.nih.gov

6. Behavior Therapy (including parent training/ABA-informed strategies)
   Description: Practical tools for routines, transitions, and positive reinforcement; coaching for caregivers. Purpose: Reduce tantrums, rigidity, aggression, or self-injury that can accompany communication delays or sensory stress. Mechanism: Consistent cues and rewards reshape learned patterns and strengthen replacement skills. ern-ithaca.eu

7. Seizure Safety Plan
   Description: Education on seizure first-aid, rescue steps, water safety, and sleep routines; school action plans. Purpose: Lower risk of injury and reduce emergency visits. Mechanism: Prepared routines and trigger management (sleep, illness, missed meds) reduce seizure likelihood and improve response time. rarediseases.info.nih.gov

8. Sleep Hygiene Program
   Description: Fixed bed/wake times, calming pre-sleep routine, light control, and consistent caregiver responses to night waking. Purpose: Improve sleep quality, daytime attention, and behavior. Mechanism: Routine anchors circadian rhythms; removing stimulating cues reduces arousal and night wakings. rarediseases.info.nih.gov

9. Feeding and Swallow Therapy
   Description: Assessment for chewing, swallowing, reflux, or food selectivity; stepwise exposure to textures and tastes. Purpose: Ensure safe growth and limit obesity risk. Mechanism: Repeated exposure and motor practice improve oral-motor skills and tolerance, while nutrition plans balance calories. rarediseases.info.nih.gov

10. Vision and Hearing Supports
    Description: Regular screening; glasses, hearing aids, or classroom FM systems when needed. Purpose: Maximize access to speech and learning. Mechanism: Clearer sensory input reduces cognitive load and helps language and school skills grow. rarediseases.info.nih.gov

11. Endocrine and Puberty Monitoring
    Description: Growth tracking, bone health checks, and puberty assessment with pediatric endocrinology. Purpose: Detect and treat hypogonadism, thyroid issues, and obesity-related risks early. Mechanism: Standard hormone care pathways address the downstream effects of PHF6-related endocrine disruption. jcrpe.org

12. Weight-management Coaching
    Description: Family-based nutrition, portion guidance, activity goals, and healthy food access. Purpose: Prevent obesity-related complications (fatty liver, insulin resistance, sleep apnea). Mechanism: Small, consistent calorie changes and daily activity slowly rebalance weight; caregiver modeling sustains habits. rarediseases.info.nih.gov

13. Dental and Orthodontic Care
    Description: Early dental visits, fluoride, and support for oral hygiene; manage bruxism or bite problems. Purpose: Reduce cavities, pain, and feeding issues. Mechanism: Preventive care interrupts the plaque–acid–enamel decay cycle; bite correction improves chewing. rarediseases.info.nih.gov

14. Assistive Technology (AT)
    Description: AAC apps, visual schedules, timers, noise-reducing headphones, and task-prompting tools. Purpose: Support communication and independence in class and at home. Mechanism: External supports reduce working-memory load and provide consistent cues to complete steps. rarediseases.info.nih.gov

15. Mental Health Counseling for Families
    Description: Coaching on stress, grief, and resilience; sibling support. Purpose: Lower caregiver burnout and improve family routines. Mechanism: Teaching coping skills and problem-solving reduces stress hormones and improves follow-through on therapies. rarediseases.info.nih.gov

16. Social and Community Services
    Description: Link to disability benefits, respite, transport, and vocational services. Purpose: Reduce financial and access barriers to care. Mechanism: Stable supports improve clinic attendance, therapy time, and school participation. rarediseases.info.nih.gov

17. Genetic Counseling
    Description: Explain X-linked inheritance and recurrence risks; discuss testing of relatives and options for future pregnancies. Purpose: Informed family planning and early detection in at-risk relatives. Mechanism: Clarifies risk and timing so families can plan care. rarediseases.info.nih.gov+1

18. Transition-to-Adulthood Planning
    Description: Prepare for adult medical care, legal rights, daily living, work skills, and guardianship or supported decision-making if needed. Purpose: Smooth hand-off from pediatric to adult services. Mechanism: Early planning closes gaps that often lead to lost care in late teens. rarediseases.info.nih.gov

19. Safety Planning and Elopement Prevention
    Description: Door alarms, ID bracelets, water safety lessons, and community notification plans if wandering risk exists. Purpose: Prevent injuries and emergencies. Mechanism: Layers of barriers and quick response plans reduce risk from impulsivity. rarediseases.info.nih.gov

20. Anesthesia and Peri-operative Planning
    Description: Share BFLS diagnosis, seizure plan, airway and tone issues with anesthesia teams. Purpose: Reduce complications during imaging or surgery. Mechanism: Tailored anesthesia choices and monitoring address BFLS-related risks. orphananesthesia.eu

---

Drug treatments

Important note: There is no FDA-approved, disease-modifying drug for BFLS itself. Medicines are chosen for specific symptoms (seizures, behavior, ADHD, anxiety/depression, endocrine issues). Doses must be individualized by your clinician. Labels below are FDA sources; they are not endorsements for BFLS, just evidence for indications, dosing ranges, and safety. rarediseases.info.nih.gov

1. Valproate (divalproex/valproic acid)
   Class: Anti-seizure. Dosage/Time: Start low and titrate; typical divided daily dosing; IV option in hospital. Purpose: Control generalized or focal seizures. Mechanism: Increases GABA and reduces neuron excitability. Side effects: Weight gain, tremor, liver toxicity, teratogenicity (avoid in pregnancy if possible). Label evidence: FDA prescribing info covers indications, dosing, and boxed warnings. FDA Access Data+2FDA Access Data+2

2. Levetiracetam (Keppra/Keppra XR)
   Class: Anti-seizure. Dosage/Time: Oral or IV; twice daily (IR) or once daily (XR). Purpose: Broad seizure control with fewer drug interactions. Mechanism: SV2A modulation reduces synaptic release. Side effects: Irritability, somnolence; monitor mood. Label evidence: FDA labels describe indications from 1 month of age and safety profile. FDA Access Data+3FDA Access Data+3FDA Access Data+3

3. Lamotrigine (Lamictal)
   Class: Anti-seizure/mood stabilizer. Dosage/Time: Slow titration to reduce rash risk. Purpose: Seizure control; may help mood. Mechanism: Inhibits voltage-gated sodium channels and glutamate release. Side effects: Rash including rare SJS/TEN, dizziness. Label evidence: Boxed warning and dosing guidance in label. FDA Access Data+2FDA Access Data+2

4. Topiramate (Topamax)
   Class: Anti-seizure. Dosage/Time: Start low, go slow; divided dosing; also used for migraine prevention in older children/adults. Purpose: Adjunct or mono-therapy for seizures. Mechanism: Multiple (GABA enhancement, AMPA antagonism, carbonic anhydrase inhibition). Side effects: Cognitive slowing, weight loss, kidney stones. Label evidence: FDA label details indications and safety. FDA Access Data+2FDA Access Data+2

5. Clobazam (Onfi)
   Class: Benzodiazepine (anti-seizure). Dosage/Time: Twice daily weight-based; adjunct in refractory epilepsy. Purpose: Short- to medium-term seizure reduction. Mechanism: GABA-A modulation increases inhibition. Side effects: Sedation, tolerance, dependence risk. Label evidence: Indications (e.g., LGS) and dosing in label. FDA Access Data+1

6. Risperidone (Risperdal)
   Class: Atypical antipsychotic. Dosage/Time: Once or twice daily; start low. Purpose: Irritability or aggression that limits care or school participation. Mechanism: Dopamine/serotonin receptor modulation. Side effects: Weight gain, prolactin rise, metabolic risks. Label evidence: FDA labeling with safety warnings. FDA Access Data

7. Aripiprazole (Abilify/Abilify Maintena/Mycite)
   Class: Atypical antipsychotic (partial D2 agonist). Dosage/Time: Daily oral; some long-acting injectables for specific indications. Purpose: Irritability or disruptive behaviors when non-drug approaches are not enough. Mechanism: Dopamine/serotonin modulation stabilizes circuits. Side effects: Akathisia, nausea, sleep changes; lower metabolic burden than some peers. Label evidence: FDA labels outline dosing and cautions. FDA Access Data+3FDA Access Data+3FDA Access Data+3

8. Methylphenidate (Ritalin)
   Class: Stimulant for ADHD. Dosage/Time: Multiple formulations; morning dosing with possible noon dose. Purpose: Improve attention, activity level, task follow-through at school. Mechanism: Increases dopamine/norepinephrine in prefrontal cortex. Side effects: Appetite loss, insomnia, irritability; misuse risk. Label evidence: FDA labels cover dosing and abuse warnings. FDA Access Data+2FDA Access Data+2

9. Lisdexamfetamine (Vyvanse)
   Class: Prodrug stimulant. Dosage/Time: Once daily morning. Purpose: ADHD symptoms impacting learning and behavior. Mechanism: Converts to d-amphetamine to raise catecholamines. Side effects: Appetite loss, insomnia, anxiety; misuse risk. Label evidence: FDA labels detail mechanism and safety. FDA Access Data+2FDA Access Data+2

10. Guanfacine ER (Intuniv)
    Class: Alpha-2A agonist (non-stimulant). Dosage/Time: Once daily; slow titration. Purpose: Reduces hyperactivity, impulsivity, tics, and sleep-onset issues. Mechanism: Strengthens prefrontal control circuits, calms sympathetic output. Side effects: Sleepiness, low blood pressure, dizziness. Label evidence: FDA label for ADHD indications and dosing. FDA Access Data+2FDA Access Data+2

11. Fluoxetine (Prozac)
    Class: SSRI. Dosage/Time: Once daily; start low. Purpose: Anxiety, obsessive features, or depression that hinders function. Mechanism: Increases serotonin signaling. Side effects: Nausea, sleep change, activation; black-box for suicidality in youth—monitor closely. Label evidence: FDA labeling with dosing and warnings. FDA Access Data+2FDA Access Data+2

12. Sertraline (Zoloft)
    Class: SSRI. Dosage/Time: Once daily; titrate gradually. Purpose: Anxiety or depression with fewer activating effects for some patients. Mechanism: Serotonin reuptake inhibition. Side effects: GI upset, sleep changes; monitor for activation. Label evidence: FDA labels detail indications and dosing. FDA Access Data+2FDA Access Data+2

13. Levothyroxine (for proven hypothyroidism only)
    Class: Thyroid hormone. Dosage/Time: Once daily on empty stomach; dose by weight and TSH/T4. Purpose: Corrects low thyroid, supporting growth, cognition, and energy. Mechanism: Replaces T4 to normalize metabolism and brain function. Side effects: Over-replacement causes palpitations, irritability, weight loss. Label evidence: FDA labels for indications and precautions. FDA Access Data+2FDA Access Data+2

14. Metformin (for insulin resistance/obesity with clinician oversight)
    Class: Biguanide antihyperglycemic. Dosage/Time: Start low with meals; XR options can aid tolerance. Purpose: Helps insulin resistance and weight-related metabolic risk when lifestyle steps are not enough. Mechanism: Lowers hepatic glucose output and improves insulin sensitivity. Side effects: GI upset, rare lactic acidosis (avoid with severe renal/hepatic disease). Label evidence: FDA labels detail dosing and safety. FDA Access Data+2FDA Access Data+2

Clinicians may consider other standard anti-seizure medicines or psychotropics case-by-case. Always weigh benefits vs. risks and interactions, and monitor growth, metabolic health, and mental health closely. FDA Access Data

---

Dietary molecular supplements (supportive; not cures)

1. Omega-3 (fish oil, EPA/DHA)
   Description: May support attention and mood and reduce inflammation. Dosage: Common pediatric ranges 500–1000 mg/day EPA+DHA (clinician guided). Function/Mechanism: Incorporates into neuron membranes, modulates neurotransmission and inflammatory pathways; may aid triglycerides and general brain health. rarediseases.info.nih.gov

2. Vitamin D
   Description: Supports bone and immune health; often low with limited outdoor time and higher weight. Dosage: Per lab values and age; avoid excess. Mechanism: Regulates calcium/bone, modulates immune and brain gene expression. rarediseases.info.nih.gov

3. Magnesium
   Description: May help cramps, constipation, and sleep. Dosage: Start low to avoid diarrhea; adjust per age. Mechanism: NMDA modulation and smooth-muscle relaxation support neuromuscular calm. rarediseases.info.nih.gov

4. Zinc
   Description: Supports growth, taste/smell, and immune function. Dosage: Age-appropriate RDA unless deficiency; monitor copper if long-term. Mechanism: Cofactor for many enzymes and synaptic function. rarediseases.info.nih.gov

5. Iron (only if deficient)
   Description: Correct iron-deficiency anemia or low ferritin. Dosage: Based on labs; can cause GI upset. Mechanism: Improves oxygen delivery and dopamine function, which supports attention and sleep. rarediseases.info.nih.gov

6. Vitamin B6/B12/Folate
   Description: Support methylation and neurotransmitter synthesis. Dosage: Meet, not exceed, recommended intakes unless deficiency. Mechanism: Co-enzymes for serotonin, dopamine, and myelin pathways. rarediseases.info.nih.gov

7. L-Carnitine
   Description: Consider if on valproate or with low energy; can reduce valproate-related carnitine depletion. Dosage: Clinician-directed; monitor for GI upset. Mechanism: Helps mitochondrial fatty-acid transport and energy production. FDA Access Data

8. Coenzyme Q10
   Description: Mitochondrial cofactor that may support energy and reduce oxidative stress. Dosage: Weight-based; variable evidence—use selectively. Mechanism: Electron transport chain support. rarediseases.info.nih.gov

9. Probiotics
   Description: May help constipation and general GI comfort. Dosage: Product-specific CFU; trial and review. Mechanism: Modulates gut flora and gut–brain signaling to improve regularity and comfort. rarediseases.info.nih.gov

10. Multivitamin (age-appropriate)
    Description: Insurance for picky eating; not a substitute for varied diet. Dosage: Once daily; avoid megadoses. Mechanism: Ensures baseline micronutrients for growth and cognition. rarediseases.info.nih.gov

---

Immunity booster / regenerative / stem cell drugs

Important safety note: There are no approved stem cell or “regenerative” drugs for BFLS. Unregulated clinics offering stem-cell infusions for genetic neurodevelopmental disorders are risky and can cause harm (infections, tumors) without proven benefit. Immune support for BFLS should rely on standard, evidence-based measures below; discuss any trials with a medical geneticist. rarediseases.info.nih.gov

1. Routine Vaccinations (per national schedule)
   Description (100 words): Protects against preventable infections (influenza, pneumococcus, COVID-19, etc.). Dosage: Age-appropriate schedules. Function/Mechanism: Trains adaptive immunity and reduces severe illness that can trigger seizures and regressions. rarediseases.info.nih.gov

2. Seasonal Influenza Vaccine
   Description: Annual shot to lower flu risk and complications. Dosage: Yearly. Mechanism: Antibody memory against circulating strains. rarediseases.info.nih.gov

3. COVID-19 Vaccination (per guidance)
   Description: Reduces severe COVID-19, hospitalizations, and long-term effects. Dosage: Primary series + boosters as advised. Mechanism: Spike-targeted immune priming. rarediseases.info.nih.gov

4. Vitamin D (immune-support role)
   Description: Correcting deficiency may support immune function. Dosage: Per labs. Mechanism: Modulates innate/adaptive immunity via vitamin D receptor signaling. rarediseases.info.nih.gov

5. Nutritional Optimization and Sleep
   Description: Adequate protein, fruits/vegetables, and 9–11 hours of sleep in children. Dosage: Lifestyle “dose.” Mechanism: Supports immune cell function, hormone balance, and seizure thresholds. rarediseases.info.nih.gov

6. Clinical-trial enrollment (when available)
   Description: Access to research-based therapies under close monitoring. Dosage: Per protocol. Mechanism: Ethical evaluation of potential treatments with safety oversight; ask your genetics team about registries. Nature

---

Surgeries

1. Orchiopexy (undescended testes)
   Why: Protect fertility potential, reduce torsion and cancer risk, and allow exam. Procedure: Day-surgery to move and fix the testis in the scrotum. rarediseases.info.nih.gov

2. Strabismus Surgery
   Why: Align eyes to improve binocular vision and reduce amblyopia. Procedure: Adjust extraocular muscles under general anesthesia. rarediseases.info.nih.gov

3. Ear Tubes (Myringotomy with Tympanostomy Tubes)
   Why: Recurrent otitis media with hearing loss affecting speech development. Procedure: Tiny tube placed to ventilate middle ear and reduce effusions. rarediseases.info.nih.gov

4. Gastrostomy Tube (G-tube)
   Why: Severe feeding dysfunction, poor growth, or unsafe swallowing. Procedure: Camera-guided or surgical placement of a small feeding tube through the abdomen. rarediseases.info.nih.gov

5. Orthopedic Procedures (e.g., for scoliosis/contractures)
   Why: Improve sitting, standing, function, and reduce pain. Procedure: Depends on severity; may include tendon lengthening or spinal fusion after bracing/therapy. rarediseases.info.nih.gov

---

Preventions

1. Genetic counseling for family planning and testing at-risk relatives. rarediseases.info.nih.gov

2. Consistent sleep routines to lower seizure risk and daytime behavior issues. rarediseases.info.nih.gov

3. Illness prevention: vaccinations, hand hygiene, timely care for fevers. rarediseases.info.nih.gov

4. Weight-gain prevention: portion control, active play/exercise most days. rarediseases.info.nih.gov

5. Dental prevention: fluoride, regular cleanings, and treatment of bruxism. rarediseases.info.nih.gov

6. Seizure trigger control: avoid missed doses; manage illness, stress, and sleep loss. rarediseases.info.nih.gov

7. Vision/hearing checks to prevent secondary learning delays. rarediseases.info.nih.gov

8. Safe home setup: water safety, secured exits if wandering risk, ID bracelet. rarediseases.info.nih.gov

9. School supports early (IEP/504) to prevent skill loss and behavior spirals. rarediseases.info.nih.gov

10. Avoid unproven “stem-cell” clinics; stick to research-backed care. rarediseases.info.nih.gov

---

When to see a doctor urgently

Seek same-day care for a first seizure, seizures lasting >5 minutes, repeated seizures without recovery, head injury, high fever with confusion, severe dehydration, breathing trouble, sudden behavior change with self-harm risk, rapid weight gain or loss, or signs of thyroid dysfunction (extreme fatigue, cold intolerance, fast heart rate). If a child stops gaining skills or loses skills they had, contact your team promptly. rarediseases.info.nih.gov

---

What to eat and what to avoid

Eat more: 1) Colorful vegetables and fruits daily; 2) Lean protein (eggs, fish, beans, yogurt); 3) High-fiber carbs (oats, brown rice, whole-grain roti); 4) Healthy fats (fish, nuts, olive/mustard oil); 5) Water as the default drink. rarediseases.info.nih.gov

Avoid/limit: 6) Sugary drinks and juices; 7) Ultra-processed snacks; 8) Large late-night meals; 9) Excess screen-time during meals; 10) Unsupervised supplements or “miracle” cures. These choices support healthy weight, better sleep, and steady energy for learning and therapies. rarediseases.info.nih.gov

---

Frequently Asked Questions (FAQs)

1. Is there a cure for BFLS?
   No. Treatment targets each symptom early and well, using therapies, school supports, and standard medicines for seizures, behavior, ADHD, and hormones. Orpha+1

2. How is BFLS diagnosed?
   By finding a disease-causing change in the PHF6 gene on a genetic test. Clinical features raise suspicion, but the gene test confirms it. rarediseases.info.nih.gov

3. Can girls have BFLS?
   Yes. Girls can have BFLS, especially with skewed X-inactivation; features may differ from boys. Nature

4. What causes seizures in BFLS?
   Brain network differences from PHF6 disruption increase excitability; standard anti-seizure medicines are used based on seizure type. ScienceDirect

5. Will my child walk and talk?
   Many children do, but later than peers, and with ongoing support from PT/OT/SLP and a tailored school plan. rarediseases.info.nih.gov

6. Is obesity inevitable?
   No. Early nutrition, activity, sleep, and endocrine checks can lower risk; clinicians may consider metformin for insulin resistance when appropriate. FDA Access Data

7. Which anti-seizure medicine is “best”?
   No single drug fits everyone. Valproate, levetiracetam, lamotrigine, topiramate, and clobazam are common choices; side-effect profiles guide selection. FDA Access Data+4FDA Access Data+4FDA Access Data+4

8. Are antipsychotics always needed for behavior?
   No. Start with behavior therapy and communication supports; consider risperidone or aripiprazole only if safety and function are limited. FDA Access Data+1

9. Do stimulants help ADHD symptoms in BFLS?
   They can. Methylphenidate or lisdexamfetamine may improve attention and activity control, with monitoring for appetite and sleep effects. FDA Access Data+1

10. Are there approved stem-cell treatments for BFLS?
    No. Avoid unproven clinics; ask about registries and ethical clinical trials through your genetics team. Nature

11. Could thyroid or puberty hormones be affected?
    Yes; endocrine issues can occur. Treat proven hormone problems using standard pathways (e.g., levothyroxine for hypothyroidism). FDA Access Data

12. What school supports help most?
    An IEP with speech, OT/PT, behavior supports, AAC, visual schedules, and calm classrooms improves access and participation. rarediseases.info.nih.gov

13. What about anesthesia for surgery or imaging?
    Share the BFLS diagnosis and seizure plan with anesthesia teams; specialized guidance exists for rare diseases. orphananesthesia.eu

14. What is the outlook?
    Disability is usually lifelong, but many skills improve with therapy, structure, and good health habits; some features may soften with age. Wikipedia

15. Where can I read more?
    Reliable summaries exist from Orphanet, NIH GARD, NORD, and recent clinical studies on PHF6-related disorders. Nature+3Orpha+3rarediseases.info.nih.gov+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 30, 2025.